Hauptinhalt

Wissenschaftliche Publikationen

Klaus Kuschinsky

Atalla A, Kuschinsky K.
Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine.
J Neural Transm. 2005 Apr 22;
 
Gronig M, Atalla A, Kuschinsky K.
Effects of dizocilpine [(+)-MK-801] on the expression of associative and non-associative sensitization to D-amphetamine.
Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):228-31. Epub 2003 Dec 12.
 
Fischer DA, Ferger B, Kuschinsky K.
Discrimination of morphine- and haloperidol-induced muscular rigidity and akinesia/catalepsy in simple tests in rats.
Behav Brain Res. 2002 Aug 21;134(1-2):317-21.
 
Themann C, Alvarez Fischer D, Gross S, Westermann R, Weihe E, Kuschinsky K, Schafer H, Ferger B.
Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
Naunyn Schmiedebergs Arch Pharmacol. 2002 Jan;365(1):22-8. Epub 2001 Nov 08.
 
Themann C, Teismann P, Kuschinsky K, Ferger B.
Comparison of two independent aromatic hydroxylation assays in combination with intracerebral microdialysis to determine hydroxyl free radicals.
J Neurosci Methods. 2001 Jul 15;108(1):57-64.
 
Alvarez Fischer D, Schafer MK, Ferger B, Gross S, Westermann R, Weihe E, Kuschinsky K.
Sensitization to the behavioural effects of cocaine: alterations in tyrosine hydroxylase or endogenous opioid mRNAs are not necessarily involved.
Naunyn Schmiedebergs Arch Pharmacol. 2001 Mar;363(3):288-94.
 
Ferger B, Kuschinsky K.
A comparison of different sensory stimuli in producing conditioned apomorphine effects.
Behav Pharmacol. 1995 Jan;6(1):40-45.
 
Afanas'ev I, Ferger B, Kuschinsky K.
The associative type of sensitization to d-amphetamine is expressed as an NO-dependent dramatic increase in extracellular dopamine in the nucleus accumbens.
Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):232-7.
 
Ferger B, Teismann P, Earl CD, Kuschinsky K, Oertel WH.
The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping.
Pharmacol Biochem Behav. 2000 Mar;65(3):425-31.
 
Ferger B, Teismann P, Earl CD, Kuschinsky K, Oertel WH.
Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice.
Naunyn Schmiedebergs Arch Pharmacol. 1999 Sep;360(3):256-61.
 
Ferger B, Spratt C, Teismann P, Seitz G, Kuschinsky K.
Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo.
Eur J Pharmacol. 1998 Nov 6;360(2-3):155-63.
 
Ferger B, Spratt C, Earl CD, Teismann P, Oertel WH, Kuschinsky K.
Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo.
Naunyn Schmiedebergs Arch Pharmacol. 1998 Sep;358(3):351-9.
 
Boonen G, Ferger B, Kuschinsky K, Haberlein H.
In vivo effects of the kavapyrones (+)-dihydromethysticin and (+/-)-kavain on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions.
Planta Med. 1998 Aug;64(6):507-10.
 
Ferger B, Boonen G, Haberlein H, Kuschinsky K.
In vivo microdialysis study of (+/-)-kavain on veratridine-induced glutamate release.
Eur J Pharmacol. 1998 Apr 24;347(2-3):211-4.
 
Ferger B, Havemann-Reinecke U, Kuschinsky K.
Dopamine and addictive diseases.
Med Monatsschr Pharm. 1997 Nov;20(11):300-9.
 
Ferger B, van Amsterdam C, Seyfried C, Kuschinsky K.
Effects of alpha-phenyl-tert-butylnitrone and selegiline on hydroxyl free radicals in rat striatum produced by local application of glutamate.
J Neurochem. 1998 Jan;70(1):276-80.
 
Stahl D, Ferger B, Kuschinsky K.
Sensitization to d-amphetamine after its repeated administration: evidence in EEG and behaviour.
Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):335-40.
 
Lienau AK, Kuschinsky K.
Sensitization phenomena after repeated administration of cocaine or D-amphetamine in rats: associative and non-associative mechanisms and the role of dopamine in the striatum.
Naunyn Schmiedebergs Arch Pharmacol. 1997 Apr;355(4):531-7.
 
Ferger B, Kuschinsky K.
Biochemical studies support the assumption that dopamine plays a minor role in the EEG effects of nicotine.
Psychopharmacology (Berl). 1997 Jan;129(2):192-6.
 
Ferger B, Stahl D, Kuschinsky K.
Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration: do they reflect sensitization phenomena?
Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):545-51.
 
Ferger B, Kuschinsky K.
Effects of morphine on EEG in rats and their possible relations to hypo- and hyperkinesia.
Psychopharmacology (Berl). 1995 Jan;117(2):200-7.
 
 
Ferger B, Kuschinsky K.
Activation of dopamine D1 receptors or alpha 1 adrenoceptors is not involved in the EEG effect of nicotine in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):346-51.
 
Dietze S, Kuschinsky K.
Effect of conditioning with d-amphetamine on the extracellular concentration of dopamine and its metabolites in the striatum of behaving rats.
Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul;350(1):22-7.
 
Ferger B, Kropf W, Kuschinsky K.
Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.
Psychopharmacology (Berl). 1994 Mar;114(2):297-308.
 
Kropf W, Kuschinsky K.
Effects of stimulation of dopamine D1 receptors on the cortical EEG in rats: different influences by a blockade of D2 receptors and by an activation of putative dopamine autoreceptors.
Neuropharmacology. 1993 May;32(5):493-500.
 
Kropf W, Kuschinsky K.
Conditioned effects of apomorphine are manifest in regional EEG of rats both in hippocampus and in striatum.
Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):487-93.
 
Welsch-Kunze S, Kleim J, Dietze S, Kuschinsky K.
Recordings of extracellular glutamate and gamma-aminobutyric acid in the striatum of non-anesthetized rats. K(+)-stimulation, its Ca(2+)-dependence and lack of effects of drugs acting on dopamine receptors.
Arzneimittelforschung. 1993 Feb;43(2):85-91.
 
Kropf W, Krieglstein J, Kuschinsky K.
Effects of stimulation of putative dopamine autoreceptors on electroencephalographic power spectrum in comparison with effects produced by blockade of postsynaptic dopamine receptors in rats.
Eur Neuropsychopharmacol. 1992 Dec;2(4):467-74.
 
Dietze S, Kuschinsky K.
Determination of extracellular glutamate after local K+ stimulation in the striatum of non-anaesthetised rats after treatment with dopaminergic drugs--studies using microdialysis.
J Neural Transm Gen Sect. 1992;90(1):1-11.
 
Kropf W, Kuschinsky K.
Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors.
Neuropharmacology. 1991 Sep;30(9):953-60.
 
Kropf W, Kuschinsky K, Krieglstein J.
Conditioning of apomorphine effects: simultaneous analysis of the alterations in cortical electroencephalogram and behaviour.
Naunyn Schmiedebergs Arch Pharmacol. 1991 Jun;343(6):559-67.
 
Wenzel J, Kuschinsky K.
Interactions between imipramine and morphine on motility in rats: possible relation to antidepressant effects?
Pharmacopsychiatry. 1990 Nov;23(6):274-8.
 
Wenzel J, Kuschinsky K.
Effects of morphine on gamma-aminobutyric acid turnover in the basal ganglia. Possible correlation with its biphasic action on motility.
Arzneimittelforschung. 1990 Jul;40(7):811-3.
 
Welsch-Kunze S, Kuschinsky K.
On the possible involvement of glutamate receptors in conditioning of behavioural effects of apomorphine.
Psychopharmacology (Berl). 1990;101(3):421-8.
 
Kropf W, Kuschinsky K, Krieglstein J.
Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors.
Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6 Pt 2):718-25.
 
Beck T, Wenzel J, Kuschinsky K, Krieglstein J.
Morphine-induced alterations of local cerebral glucose utilization in the basal ganglia of rats.
Brain Res. 1989 Sep 18;497(2):205-13.
 
Kuschinsky K.
The conditioning of drug effects. A pathway for research on placebo effects?
Dtsch Med Wochenschr. 1989 Jul 28;114(30):1171-4.
 
Walter S, Kuschinsky K.
Conditioning of morphine-induced locomotor activity and stereotyped behaviour in rats.
J Neural Transm Gen Sect. 1989;78(3):231-47.
 
Walter S, Kuschinsky K.
Conditioning of nicotine effects on motility and behaviour in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):208-13.
 
Welsch-Kunze S, Nowak K, Kuschinsky K.
Conditioned behavioural responses to apomorphine: extinction and haloperidol-induced inhibition.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):671-7.
 
Nowak K, Welsch-Kunze S, Kuschinsky K.
Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Apr;337(4):385-91.
 
Nowak K, Kuschinsky K.
Conditioning of behavioural effects produced by an intermediate dose of apomorphine: hypokinesia, ptosis and stereotypies.
Naunyn Schmiedebergs Arch Pharmacol. 1987 Sep;336(3):262-6.
 
Beck T, Moller HG, Nowak K, Krieglstein J, Kuschinsky K.
Alterations in regional energy metabolism in rat brain produced by small and by large doses of apomorphine: possible relations to autoreceptors.
Eur J Pharmacol. 1987 Jul 9;139(2):139-46.
 
Moller HG, Nowak K, Kuschinsky K.
Studies on interactions between conditioned and unconditioned behavioural responses to apomorphine in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1987 Jun;335(6):673-9.
 
Moller HG, Nowak K, Kuschinsky K.
Conditioning of pre- and post-synaptic behavioural responses to the dopamine receptor agonist apomorphine in rats.
Psychopharmacology (Berl). 1987;91(1):50-5.
 
Nowak K, Moller HG, Kuschinsky K.
Conditioning of behavioural signs produced by nomifensine and by B-HT 920 in rats.
Psychopharmacology (Berl). 1987;93(2):182-7.
 
 
Moller HG, Kuschinsky K.
Interactions of morphine with apomorphine: behavioural and biochemical studies.
Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):452-7.
 
Themann P, Havemann U, Kuschinsky K.
On the mechanisms of the development of tolerance to the muscular rigidity produced by morphine in rats.
Eur J Pharmacol. 1986 Oct 7;129(3):315-21.
 
Havemann U, Magnus B, Moller HG, Kuschinsky K.
Individual and morphological differences in the behavioural response to apomorphine in rats.
Psychopharmacology (Berl). 1986;90(1):40-8.
 
Havemann U, Kuschinsky K
Locomotor activity of rats after injection of various opioids into the nucleus accumbens and the septum mediale.
Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov;331(2-3):175-80.
 
Melzacka M, Nesselhut T, Havemann U, Vetulani J, Kuschinsky K.
Pharmacokinetics of morphine in striatum and nucleus accumbens: relationship to pharmacological actions.
Pharmacol Biochem Behav. 1985 Aug;23(2):295-301.
 
Themann P, Havemann U, Kuschinsky K.
Development of tolerance to the muscular rigidity produced by morphine and replacement by stereotypic behaviour.
Neuropeptides. 1984 Dec;5(1-3):27-8.
 
Turski L, Havemann U, Kuschinsky K.
GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: differences between dorsal and ventral striatum.
Brain Res. 1984 Nov 19;322(1):49-57.
 
Turski L, Havemann U, Kuschinsky K.
Role of muscarinic cholinergic mechanisms in the substantia nigra pars reticulata in mediating muscular rigidity in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):14-7.
 
Antkiewicz-Michaluk L, Havemann U, Vetulani J, Wellstein A, Kuschinsky K.
Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid.
Life Sci. 1984 Jul 23;35(4):347-55.
 
Herz A, Havemann U, Kuschinsky K.
Mediator of analgesia and addiction. Control point mechanism of opiate receptors.
MMW Munch Med Wochenschr. 1983 Sep 16;125(37):105-6.
 
Turski L, Havemann U, Kuschinsky K.
The role of the substantia nigra in motility of the rat. Muscular rigidity, body asymmetry and catalepsy after injection of morphine into the nigra.
Neuropharmacology. 1983 Sep;22(9):1039-48.
 
Havemann U, Turski L, Schwarz M, Kuschinsky K.
Nigral GABAergic mechanisms and EMG activity in rats: differences between pars reticulata and pars compacta.
Eur J Pharmacol. 1983 Aug 19;92(1-2):49-56.
 
Genc E, Havemann U, Tzoneva-Tyutyulkova N, Kuschinsky K.
Motility, rigidity and turnover of dopamine in the striatum after administration of morphine to rats: a re-evaluation of their mechanisms.
Neuropharmacology. 1983 Apr;22(4):471-6.
 
Turski L, Havemann U, Kuschinsky K.
Reversal of the muscle relaxant effect of diazepam by the specific benzodiazepine antagonist Ro 15-1788: an electromyographic study in morphine model of muscular rigidity in rats.
Life Sci. 1983;33 Suppl 1:755-8.
 
Havemann U, Winkler M, Kuschinsky K.
The effects of D-ala2, D-Leu5-enkephalin injections into the nucleus accumbens on the motility of rats.
Life Sci. 1983;33 Suppl 1:627-30.
 
Turski L, Havemann U, Schwarz M, Kuschinsky K.
Disinhibition of nigral GABA output neurons mediates muscular rigidity elicited by striatal opioid receptor stimulation.
Life Sci. 1982 Nov 15-22;31(20-21):2327-30.
 
Havemann U, Turski L, Kuschinsky K.
Role of opioid receptors in the substantia nigra in morphine-induced muscular rigidity.
Life Sci. 1982 Nov 15-22;31(20-21):2319-22.
 
Turski L, Havemann U, Kuschinsky K.
On the possible role of excitatory amino acids in the striatum in mediating morphine-induced muscular rigidity.
Pharmacol Biochem Behav. 1982 Oct;17(4):715-9.
 
Havemann U, Winkler M, Kuschinsky K.
Is morphine-induced akinesia related to inhibition of reflex activation of flexor alpha-motoneurones? Role of the nucleus accumbens.
Naunyn Schmiedebergs Arch Pharmacol. 1982 Aug;320(2):101-4.
 
Turski L, Havemann U, Kuschinsky K.
Evidence that opioid receptors in the substantia nigra pars reticulata are relevant in regulating the function of striatal efferent pathways.
Behav Brain Res. 1982 Aug;5(4):415-22.
 
Havemann U, Turski L, Kuschinsky K.
Role of GABAergic mechanisms in the substantia nigra pars reticulata in modulating morphine-i induced muscular rigidity in rats.
Neurosci Lett. 1982 Jul 20;31(1):25-30.
 
Turski L, Havemann U, Kuschinsky K.
Evidence for functional interactions of morphine in substantia nigra and striatum in relation to muscular rigidity in rats.
Neurosci Lett. 1982 Mar 5;28(3):291-6.
 
Winkler M, Havemann U, Kuschinsky K.
Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1982 Feb;318(3):143-7.
 
Antkiewicz-Michaluk L, Vetulani J, Havemann U, Kuschinsky K.
3H-dihydromorphine binding sites in subcellular fractions of rat striatum.
Pol J Pharmacol Pharm. 1982;34(1-3):73-8.
 
Havemann U, Winkler M, Genc E, Kuschinsky K.
Effects of striatal lesions with kainic acid on morphine-induced "catatonia" and increase of striatal dopamine turnover.
Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):44-50.
 
Havemann U, Kuschinsky K.
Further characterization of opioid receptors in the striatum mediating muscular rigidity in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1981;317(4):321-5.
 
Kuschinsky K.
Opiate-like analgesics
Arzneimittelforschung. 1981;Suppl 27:50-2.
 
Havemann U, Winkler M, Kuschinsky K.
Opioid receptors in the caudate nucleus can mediate EMG-recorded rigidity in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(2):139-44.
 
Langer J, Seeber U, Kuschinsky K, Sontag KH.
Effect of haloperidol on reflex activation of rat alpha-motoneurones. A possible explanation for akinesia and catalepsy?
Naunyn Schmiedebergs Arch Pharmacol. 1979 Aug;308(2):149-54.
 
Kuschinsky K.
On the physiology and pharmacology of endorphins (author's transl)
Klin Wochenschr. 1979 Jul 15;57(14):701-10. German.
 
Havemann U, Kuschinsky K.
Effect of morphine of prostaglandin E2 (PGE2)-sensitive adenylate cyclase in corpus striatum of rats and its cellular localization by using kainic acid.
Brain Res. 1978 Jul 14;150(2):441-5. No abstract available.
 
Havemann U, Kuschinsky K.
Interactions of opiates and prostaglandins E with regard to cyclic AMP in striatal tissue of rats in vitro.
Naunyn Schmiedebergs Arch Pharmacol. 1978 Mar 16;302(1):103-6.
 
Seeber U, Kuschinsky K, Sontag KH.
Inhibition by opiate narcotics of rat flexor alpha-motoneurones.
Naunyn Schmiedebergs Arch Pharmacol. 1978 Jan-Feb;301(3):181-5.
 
Bosse A, Kuschinsky K.
Potassium-induced release of 14C-dopamine from synaptosomes of corpus striatum of rats: effects of morphine.
Arzneimittelforschung. 1978;28(11):2100-2.
 
Havemann U, Kuschinsky K.
Effects of opiates on cAMP in homogenates and slices of rat striata.
Pharmacology. 1978;16(5):295-9.
 
Kuschinsky K, Ropte H, Meseke R, Cremer H, Sontag KH.
Specific action of narcotics on reflex activation of rat alpha-motoneurones.
Naunyn Schmiedebergs Arch Pharmacol. 1977 Feb;296(3):249-54.
 
Seeber U, Kuschinsky K.
Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats. Experientia. 1976 Dec 15;32(12):1558-9.
 
Kuschinsky K, Groppe G, Bosse A.
On the relevance of serotoninergic-dopaminergic interactions in effects of morphine in rats.
Pol J Pharmacol Pharm. 1976 Nov-Dec;28(6):587-8. No abstract available.
 
Seeber U, Kuschinsky K.
Dopamine-sensitive adenylate cyclase in homogenates of rat striata during ethanol and barbiturate withdrawal.
Arch Toxicol. 1976 Aug 18;35(4):247-53.
 
Bosse A, Kuschinsky K.
Alterations of dopaminergic neurotransmission after chronic morphine treatment: pre- and postjunctional studies in striatal tissue.
Naunyn Schmiedebergs Arch Pharmacol. 1976 Jul 16;294(1):17-22.
 
Kuschinsky K.
Actions of narcotics on brain dopamine metabolism and their relevance for "psychomotor" effects.
Arzneimittelforschung. 1976 Apr;26(4):563-7. Review.
 
Freye E, Kuschinsky K.
Effects of fentanyl and droperidol on the dopamine metabolism of the rat striatum.
Pharmacology. 1976;14(1):1-7.
 
Groppe G, Kuschinsky K.
Stimulation and inhibition of serotoninergic mechanisms in rat brain: alterations of morphine effects on striatal dopamine metabolism and on motility.
Neuropharmacology. 1975 Sep;14(9):659-64.
 
Kuschinsky K, Celsen B, Huppertz A.
Studies on dopamine kinetics in rat brain tissue under the influence of morphine.
Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):129-33.
 
Kuschinsky K.
Dopamine receptor sensitivity after repeated morphine administrations to rats.
Life Sci. 1975 Jul 1;17(1):43-8.
 
Kuschinsky K.
Cellular effect of neuroleptics
Dtsch Med Wochenschr. 1975 Jun 20;100(25):1405-8.
 
Kuschinsky K.
Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
Psychopharmacologia. 1975 Jun 19;42(3):225-9.
 
Kuschinsky K.
Proceedings: Effect of repeated applications of morphine on the sensitivity of dopamine receptors in brain. Naunyn Schmiedebergs Arch Pharmacol. 1975;287 Suppl:R15.
 
Kuschinsky K, Hornykiewicz O.
Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
Eur J Pharmacol. 1974 Apr;26(1):41-50.
 
Kuschinsky K, Celsen B.
Proceedings: Kinetics of 14C-dopamine in isolated rat striatal tissue under the influence of morphine.
Naunyn Schmiedebergs Arch Pharmacol. 1974 Mar 22;282(0):suppl 282:R54.
 
Kuschinsky K.
Are cholinergic mechanisms involved in morphine effects on motility?
Naunyn Schmiedebergs Arch Pharmacol. 1974 Feb 5;281(2):167-73.
 
Celsen B, Kuschinsky K.
Effects of morphine on kinetics of 14C-dopamine in rat striatal slices.
Naunyn Schmiedebergs Arch Pharmacol. 1974;284(2):159-65.
 
Kuschinsky K.
Evidence that morphine increases dopamine utilization in corpora striata of rats.
Experientia. 1973 Nov 15;29(11):1365-6
 
Wand P, Kuschinsky K, Sontag KH.
Morphine-induced muscular rigidity in rats.
Eur J Pharmacol. 1973 Nov;24(2):189-93.
 
Kuschinsky K, Seidel G, Reetz E, Meyer-Burgdorf C.
The effect of pentobarbital on brain 5-HT metabolism in mice.
Experientia. 1973;29(7):826-7. No abstract available.
 
Kuschinsky K, Hornykiewicz O.
Morphine catalepsy in the rat: relation to striatal dopamine metabolism.
Eur J Pharmacol. 1972 Jul;19(1):119-22.
 
Kuschinsky K.
Recent views on the biochemical aspects of the mode of action of analgesics acting like morphine in the central nervous system
Klin Wochenschr. 1972 Apr 15;50(8):401-9. Review.
 
Rieger J, Kuschinsky K.
The effect of protein binding on the uptake of ouabain and digitoxin into the perfused heart preparation.
Naunyn Schmiedebergs Arch Pharmacol. 1972;274(3):238-45.
 
Kuschinsky K.
Effect of morphine on protein synthesis in synaptosomes and mitochondria of mouse brain in vivo. Naunyn Schmiedebergs Arch Pharmakol. 1971;271(3):294-300. No abstract available.
 
Kuschinsky K.
The specifity of the binding of some cardenolides to human serum albumin.
Arzneimittelforschung. 1970 Jun;20(6):842-5.
 
Kuschinsky K, van Zwieten PA.
On the cumulation of digitoxin and digitoxigenin in isolated heart muscle preparations.
J Pharm Pharmacol. 1969 Jun;21(6):398-9.
 
Kuschinsky K.
Accumulation of cardiac glycosides.
Ger Med Mon. 1969 Apr;14(4):198-202. Review.
 
Kuschinsky K, van Zwieten PA.
Kinetic studies with 3H-digitoxigenin on the isolated atria of guinea pigs
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;263(1):234.
 
Kuschinsky K.
On the characteristics of the binding of cardiac glycosides by plasma proteins
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;262(3):388-98.
 
Kuschinsky K, van Zwieten PA.
Behavior of digoxin, digitoxin and digitoxigenin in isolated heart muscle and in plasma of reserpinized guinea pigs.
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;262(4):463-73.
 
Kuschinsky K, Lullmann H, van Zwieten PA.
The binding of 3H-peruvoside by guinea pig isolated atria.
Arzneimittelforschung. 1968 Dec;18(12):1602-5.
 
Kuschinsky K.
On the problem of cardiac glycoside accumulation
Dtsch Med Wochenschr. 1968 Nov 29;93(48):2344-7. Review.
 
Kuschinsky K, Lullmann H, van Zwieten PA.
The binding of 3H-digitoxigenin by guinea-pig atrial tissue.
Br J Pharmacol. 1968 Nov;34(3):613-22.
 
Kuschinsky K, Lullmann H, Van Zwieten PA.
The uptake of 3H-ouabain and 3H-digitoxin by guinea pig atria, previously extracted with glycerol.
Eur J Pharmacol. 1968 Sep;4(2):228-30.
 
Kuschinsky K, Lullmann H, van Zwieten PA.
A comparison of the accumulation and release of 3H-ouabain and 3H-digitoxin by guinea-pig heart muscle.
Br J Pharmacol. 1968 Mar;32(3):598-608.
 
Kuschinsky K.
Binding of various cardiac glycosides to plasma proteins.
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;260(2):165.
 
Kuschinsky K.
Determination of protein binding of different cardiac glycosides by means of Sephadex gel filtration.
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;259(5):394-9.
 
Kuschinsky K, Lullmann H, Schmitz G, van Zwieten PA.
On the problem of binding of H3-digoxin by myocardial tissue.
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967 Sep 15;258(3):297-308.
 
Kuschinsky K, Lahrtz H, Lullmann H, van Zwieten PA.
Accumulation and release of 3H-digoxin by guinea-pig heart muscle.
Br J Pharmacol. 1967 Jun;30(2):317-28.